Identification of histidine kinase inhibitors through screening of natural compounds to combat mastitis caused by Streptococcus agalactiae in dairy cattle DOI Creative Commons
Rajesh Kumar Pathak, Jun‐Mo Kim

Journal of Biological Engineering, Год журнала: 2023, Номер 17(1)

Опубликована: Сен. 26, 2023

Mastitis poses a major threat to dairy farms globally; it results in reduced milk production, increased treatment costs, untimely compromised genetic potential, animal deaths, and economic losses. Streptococcus agalactiae is highly virulent bacteria that cause mastitis. The administration of antibiotics for the this infection not advised due concerns about emergence antibiotic resistance potential adverse effects on human health. Thus, there critical need identify new therapeutic approaches combat One promising target development antibacterial therapies transmembrane histidine kinase bacteria, which plays key role signal transduction pathways, secretion systems, virulence, resistance.In study, we aimed novel natural compounds can inhibit kinase. To achieve goal, conducted virtual screening 224,205 compounds, selecting top ten based their lowest binding energy favorable protein-ligand interactions. Furthermore, molecular docking eight selected five inhibitors with was performed evaluate respect top-screened compounds. We also analyzed ADMET properties these assess drug-likeness. two (ZINC000085569031 ZINC000257435291) (Tetracycline) demonstrated strong affinity were subjected dynamics simulations (100 ns), free landscape, calculations using MM-PBSA method.Our suggest have serve as effective be utilized veterinary medicine mastitis after further validation through clinical studies.

Язык: Английский

High-throughput prediction of protein conformational distributions with subsampled AlphaFold2 DOI Creative Commons
Gabriel Monteiro da Silva, Jennifer Y. Cui, David C. Dalgarno

и другие.

Nature Communications, Год журнала: 2024, Номер 15(1)

Опубликована: Март 27, 2024

Abstract This paper presents an innovative approach for predicting the relative populations of protein conformations using AlphaFold 2, AI-powered method that has revolutionized biology by enabling accurate prediction structures. While 2 shown exceptional accuracy and speed, it is designed to predict proteins’ ground state limited in its ability conformational landscapes. Here, we demonstrate how can directly different subsampling multiple sequence alignments. We tested our against nuclear magnetic resonance experiments on two proteins with drastically amounts available data, Abl1 kinase granulocyte-macrophage colony-stimulating factor, predicted changes their more than 80% accuracy. Our worked best when used qualitatively effects mutations or evolution landscape well-populated states proteins. It thus offers a fast cost-effective way at even single-point mutation resolution, making useful tool pharmacology, analysis experimental results, evolution.

Язык: Английский

Процитировано

80

Advances in AI for Protein Structure Prediction: Implications for Cancer Drug Discovery and Development DOI Creative Commons
Xinru Qiu, H. Li, Greg Ver Steeg

и другие.

Biomolecules, Год журнала: 2024, Номер 14(3), С. 339 - 339

Опубликована: Март 12, 2024

Recent advancements in AI-driven technologies, particularly protein structure prediction, are significantly reshaping the landscape of drug discovery and development. This review focuses on question how these technological breakthroughs, exemplified by AlphaFold2, revolutionizing our understanding function changes underlying cancer improve approaches to counter them. By enhancing precision speed at which targets identified candidates can be designed optimized, technologies streamlining entire development process. We explore use AlphaFold2 development, scrutinizing its efficacy, limitations, potential challenges. also compare with other algorithms like ESMFold, explaining diverse methodologies employed this field practical effects differences for application specific algorithms. Additionally, we discuss broader applications including prediction complex structures generative design novel proteins.

Язык: Английский

Процитировано

30

Review of AlphaFold 3: Transformative Advances in Drug Design and Therapeutics DOI Open Access
Dev Desai,

Shiv V Kantliwala,

Jyothi Vybhavi

и другие.

Cureus, Год журнала: 2024, Номер unknown

Опубликована: Июль 2, 2024

Google DeepMind Technologies Limited (London, United Kingdom) recently released its new version of the biomolecular structure predictor artificial intelligence (AI) model named AlphaFold 3. Superior in accuracy and more powerful than predecessor 2, this innovation has astonished world with capacity speed. It takes humans years to determine various proteins how shape works receptors but 3 predicts same seconds. The version's utility is unimaginable field drug discoveries, vaccines, enzymatic processes, determining rate effect different biological processes. uses similar machine learning deep models such as Gemini (Google Limited). already established itself a turning point computational biochemistry development along receptor modulation development. With help this, researchers will gain unparalleled insights into structural dynamics their interactions, opening up avenues for scientists doctors exploit benefit patient. integration AI like 3, bolstered by rigorous validation against high-standard research publications, set catalyze further innovations offer glimpse future biomedicine.

Язык: Английский

Процитировано

28

Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis DOI Creative Commons
Zhenhui Wu, Shupeng Chen, Yihao Wang

и другие.

International Journal of Surgery, Год журнала: 2024, Номер unknown

Опубликована: Март 19, 2024

Computer-aided drug design (CADD) is a technique for computing ligand-receptor interactions and involved in various stages of development. To better grasp the frontiers hotspots CADD, we conducted review analysis through bibliometrics.

Язык: Английский

Процитировано

24

The Role of AI in Drug Discovery DOI Creative Commons
M.K.G. Abbas,

Abrar Rassam,

Fatima Karamshahi

и другие.

ChemBioChem, Год журнала: 2024, Номер 25(14)

Опубликована: Май 13, 2024

The emergence of Artificial Intelligence (AI) in drug discovery marks a pivotal shift pharmaceutical research, blending sophisticated computational techniques with conventional scientific exploration to break through enduring obstacles. This review paper elucidates the multifaceted applications AI across various stages development, highlighting significant advancements and methodologies. It delves into AI's instrumental role design, polypharmacology, chemical synthesis, repurposing, prediction properties such as toxicity, bioactivity, physicochemical characteristics. Despite promising advancements, also addresses challenges limitations encountered field, including data quality, generalizability, demands, ethical considerations. By offering comprehensive overview discovery, this underscores technology's potential significantly enhance while acknowledging hurdles that must be overcome fully realize its benefits.

Язык: Английский

Процитировано

20

Advancements in small molecule drug design: A structural perspective DOI Creative Commons
Ke Wu,

Eduard Karapetyan,

John V. Schloss

и другие.

Drug Discovery Today, Год журнала: 2023, Номер 28(10), С. 103730 - 103730

Опубликована: Авг. 1, 2023

Язык: Английский

Процитировано

42

Deep learning in structural bioinformatics: current applications and future perspectives DOI Creative Commons
Niranjan Kumar, Rakesh Srivastava

Briefings in Bioinformatics, Год журнала: 2024, Номер 25(3)

Опубликована: Март 27, 2024

Abstract In this review article, we explore the transformative impact of deep learning (DL) on structural bioinformatics, emphasizing its pivotal role in a scientific revolution driven by extensive data, accessible toolkits and robust computing resources. As big data continue to advance, DL is poised become an integral component healthcare biology, revolutionizing analytical processes. Our comprehensive provides detailed insights into DL, featuring specific demonstrations notable applications bioinformatics. We address challenges tailored for spotlight recent successes bioinformatics present clear exposition DL—from basic shallow neural networks advanced models such as convolution, recurrent, artificial transformer networks. This paper discusses emerging use understanding biomolecular structures, anticipating ongoing developments realm

Язык: Английский

Процитировано

16

Exploring structural diversity across the protein universe with The Encyclopedia of Domains DOI
Andy M. Lau, Nicola Bordin, Shaun M. Kandathil

и другие.

Science, Год журнала: 2024, Номер 386(6721)

Опубликована: Окт. 31, 2024

The AlphaFold Protein Structure Database (AFDB) contains more than 214 million predicted protein structures composed of domains, which are independently folding units found in multiple structural and functional contexts. Identifying domains can enable many evolutionary analyses but has remained challenging because the sheer scale data. Using deep learning methods, we have detected classified every domain AFDB, producing Encyclopedia Domains. We nearly 365 over 100 be by sequence covering 1 taxa. Reassuringly, 77% nonredundant similar to known superfamilies, greatly expanding representation their space. uncovered 10,000 new interactions between superfamilies thousands folds across fold space continuum.

Язык: Английский

Процитировано

13

AlphaFold3 versus experimental structures: assessment of the accuracy in ligand-bound G protein-coupled receptors DOI
Xinheng He, Jia Li,

Shi-yi Shen

и другие.

Acta Pharmacologica Sinica, Год журнала: 2024, Номер unknown

Опубликована: Дек. 6, 2024

Язык: Английский

Процитировано

12

The current role and evolution of X-ray crystallography in drug discovery and development DOI
Vanessa Bijak, Michal Szczygiel, Joanna Lenkiewicz

и другие.

Expert Opinion on Drug Discovery, Год журнала: 2023, Номер 18(11), С. 1221 - 1230

Опубликована: Авг. 17, 2023

Macromolecular X-ray crystallography and cryo-EM are currently the primary techniques used to determine three-dimensional structures of proteins, nucleic acids, viruses. Structural information has been critical drug discovery structural bioinformatics. The integration artificial intelligence (AI) into shown great promise in automating accelerating analysis complex data, further improving efficiency accuracy structure determination.

Язык: Английский

Процитировано

20